Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Anthem (ANTM) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Anthem's (ANTM) third-quarter results are likely to reflect gains from increased premiums, and strong membership growth across its Medicare and Medicaid businesses, partly offset by rising expenses.
UnitedHealth (UNH) Beats on Q3 Earnings & Revenues, Ups View
by Zacks Equity Research
UnitedHealth (UNH) Q3 results reflect revenue growth at both the business units and increased membership.
Anthem (ANTM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Anthem (ANTM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Anthem's (ANTM) MA Members to be Covered Under Highly Rated Plans
by Zacks Equity Research
Anthem's (ANTM) 72% Medicare Advantage members to be covered under highly rated plans starting 2022. The ratings reflect the company's commitment to provide better healthcare.
Molina (MOH) to Buy AgeWell's Medicaid Long Term Care Business
by Zacks Equity Research
Molina (MOH) inks a deal to acquire certain assets of AgeWell New York's Medicaid Managed Care Business for a value of $110M.
What's in Store for UnitedHealth's (UNH) Earnings in Q3?
by Zacks Equity Research
UnitedHealth's (UNH) Q3 results are likely to report a rise in earnings and revenues.
Why Should You Hold Onto Anthem (ANTM) in Your Portfolio?
by Zacks Equity Research
A solid positioning in an ever-growing industry along with strong fundamentals make Anthem (ANTM) a good fit for investment gains.
Why Should You Hold Molina Healthcare (MOH) in Your Portfolio?
by Zacks Equity Research
Riding high on strategic measures and membership growth, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
UnitedHealth (UNH) Woos MA Members With Updated 2022 Plans
by Zacks Equity Research
UnitedHealth (UNH) announces MA plans for 2022 to maintain its leadership position in the market.
3 HMO Stocks That Outperformed the S&P Index in a Year's Time
by Srijita Guha
Membership growth, mergers and buyouts, and investment in technology are likely to aid health insurance companies like ANTM, MOH, and UNH to outperform the S&P Index.
Here is Why UnitedHealth (UNH) Should Grace Your Portfolio
by Zacks Equity Research
A solid positioning in an ever-growing industry makes UnitedHealth (UNH) a top pick for strong investment gains.
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Humana and Centene Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Humana and Centene Corp
4 HMO Stocks in Focus as Government Backs Healthcare Reform
by Sapna Bagaria
The Health insurance industry is poised to grow on the back of a better regulatory environment. Aging demography, automation plus mergers and acquisitions are other catalysts.
Why Anthem (ANTM) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Should You Hold Centene (CNC) in Your Portfolio Now?
by Zacks Equity Research
Riding high on strategic initiatives and operational excellence, Centene (CNC) holds potential to reap benefits for investors.
Are Investors Undervaluing Anthem (ANTM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights: Eli Lilly, Exxon Mobil, Lowe's, General Electric and Anthem
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Eli Lilly, Exxon Mobil, Lowe's, General Electric and Anthem
Top Research Reports for Eli Lilly, Exxon Mobil & Lowe's
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Exxon Mobil Corporation (XOM), and Lowe's Companies, Inc. (LOW).
Here's Why Anthem (ANTM) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Centene vs. Anthem: Which is a Better-Positioned Stock?
by Zacks Equity Research
Centene (CNC) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which stock is more profitable, based on the fundamentals.
Why Should You Hold onto Anthem (ANTM) in Your Portfolio?
by Zacks Equity Research
Riding high on growing revenues, solid guidance and strategic initiatives, Anthem (ANTM) holds potential to reap benefits for investors.
Should Value Investors Buy Anthem (ANTM) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Hologic (HOLX) Acessa Procedure Gets Anthem Insurance Coverage
by Zacks Equity Research
Hologic's (HOLX) Acessa Procedure's new coverage upholds Laparoscopic Radiofrequency Ablation for women suffering from uterine fibroids.
UnitedHealth (UNH) Hits 52-Week High: Hold it for Steady Growth
by Zacks Equity Research
UnitedHealth's (UNH) business diversification, presence in the niche markets and balance sheet strength make it a stock to be retained for long-term gains.
Why Is Anthem (ANTM) Down 2.2% Since Last Earnings Report?
by Zacks Equity Research
Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.